Eloxx Pharmaceuticals, Inc. · NASDAQ:ELOX
Nantahala Capital Management, LLC reported a 9.91% stake in Eloxx Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Nantahala Capital Management, LLC reported a 9.91% stake in Eloxx Pharmaceuticals, Inc., 400,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 9.91%
- Shares
- 400,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 9.91% | 400,000 |
| Wilmot B. Harkey | 9.91% | 400,000 |
| Daniel Mack | 9.91% | 400,000 |
Source
Related
- Eloxx Pharmaceuticals, Inc.
- Nantahala Capital Management, LLC
- Eloxx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Srinivas Akkaraju · Aug 14, 2026
- Schedule 13G · Domicilium Capital Partners LLC · Jun 17, 2026
- Schedule 13G · EcoR1 Capital, LLC · Jun 16, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 16, 2026
- Schedule 13G · Invus Public Equities, L.P. · Jun 15, 2026